TERRACCIANO, DANIELA
 Distribuzione geografica
Continente #
AS - Asia 8.557
NA - Nord America 7.560
EU - Europa 5.922
SA - Sud America 982
AF - Africa 266
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 23.300
Nazione #
US - Stati Uniti d'America 7.193
SG - Singapore 3.461
RU - Federazione Russa 2.567
VN - Vietnam 1.834
CN - Cina 1.586
IT - Italia 1.402
BR - Brasile 754
HK - Hong Kong 557
DE - Germania 429
FR - Francia 271
NL - Olanda 269
GB - Regno Unito 230
BD - Bangladesh 221
FI - Finlandia 219
IN - India 206
CA - Canada 179
JP - Giappone 156
KR - Corea 104
UA - Ucraina 104
MX - Messico 103
AR - Argentina 92
CI - Costa d'Avorio 81
IE - Irlanda 81
SE - Svezia 68
PL - Polonia 67
PH - Filippine 63
TH - Thailandia 54
ZA - Sudafrica 54
IQ - Iraq 51
ES - Italia 50
ID - Indonesia 40
TR - Turchia 36
AT - Austria 33
NG - Nigeria 33
EC - Ecuador 30
CO - Colombia 28
PK - Pakistan 26
LT - Lituania 25
TW - Taiwan 20
JO - Giordania 18
KE - Kenya 18
PY - Paraguay 18
VE - Venezuela 18
JM - Giamaica 17
CL - Cile 15
UZ - Uzbekistan 14
CZ - Repubblica Ceca 13
DK - Danimarca 13
EG - Egitto 13
TN - Tunisia 13
MY - Malesia 12
PE - Perù 12
AE - Emirati Arabi Uniti 10
AZ - Azerbaigian 10
BE - Belgio 10
GR - Grecia 9
MA - Marocco 9
NP - Nepal 9
BO - Bolivia 8
CH - Svizzera 8
CR - Costa Rica 8
DO - Repubblica Dominicana 8
IL - Israele 8
SA - Arabia Saudita 8
GT - Guatemala 7
IR - Iran 7
RO - Romania 7
TT - Trinidad e Tobago 7
BG - Bulgaria 6
DZ - Algeria 6
LV - Lettonia 6
PT - Portogallo 6
RS - Serbia 6
ET - Etiopia 5
GA - Gabon 5
HN - Honduras 5
LC - Santa Lucia 5
PA - Panama 5
PS - Palestinian Territory 5
AU - Australia 4
BA - Bosnia-Erzegovina 4
BS - Bahamas 4
CY - Cipro 4
NI - Nicaragua 4
OM - Oman 4
SI - Slovenia 4
SY - Repubblica araba siriana 4
UY - Uruguay 4
AL - Albania 3
AM - Armenia 3
AO - Angola 3
BB - Barbados 3
GE - Georgia 3
GM - Gambi 3
KG - Kirghizistan 3
KH - Cambogia 3
KZ - Kazakistan 3
NA - Namibia 3
NZ - Nuova Zelanda 3
PR - Porto Rico 3
Totale 23.236
Città #
Singapore 1.748
San Jose 1.302
Ashburn 804
Moscow 543
Hong Kong 528
Chandler 490
Beijing 477
Ho Chi Minh City 468
Naples 414
Hanoi 400
Hefei 378
Santa Clara 301
Los Angeles 242
Amsterdam 205
Munich 177
Lauterbourg 168
New York 161
Dallas 152
Dong Ket 148
Tokyo 127
The Dalles 116
Council Bluffs 105
Millbury 97
Boston 96
Napoli 91
São Paulo 86
Da Nang 83
Jacksonville 81
Buffalo 77
Milan 75
Redondo Beach 72
Seoul 70
Turku 70
Orem 67
Rome 67
Haiphong 66
Princeton 61
Des Moines 60
Helsinki 58
Lawrence 58
Frankfurt am Main 57
London 55
Warsaw 55
Nanjing 54
Mexico City 52
Wilmington 52
Brooklyn 51
Chicago 51
Houston 49
Montreal 47
Denver 46
Seattle 45
Kochi 44
Atlanta 42
Chennai 42
Boardman 41
Toronto 40
Phoenix 39
Lappeenranta 38
Ottawa 35
Poplar 34
Nuremberg 32
Abuja 31
Bari 29
Biên Hòa 29
Johannesburg 28
Baghdad 24
Casamassima 24
Woodbridge 23
San Francisco 22
Brasília 21
Can Tho 21
Dearborn 21
Düsseldorf 21
Rio de Janeiro 21
Stockholm 21
Washington 21
Bangkok 20
Hải Dương 20
Dublin 19
Falkenstein 19
Ankara 18
Tianjin 18
Charlotte 17
Nanchang 17
Amman 16
Curitiba 16
Guangzhou 16
Manchester 16
Ninh Bình 16
Fairfield 15
Hebei 15
Mumbai 15
Nairobi 15
Philadelphia 15
Pune 15
Querétaro 15
Vienna 15
Bắc Giang 14
Changsha 14
Totale 12.523
Nome #
The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial 291
The Biological Role of Vitamins in Athletes’ Muscle, Heart and Microbiota 224
Impaired Seroconversion After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccine in Patients With Thymic Epithelial Tumors 201
System for the automated sanitization of containers for biological samples and its process of use 200
Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-Line Sunitinib (QUASAR): Results of a Phase I Trial 200
Falsely elevated thyroglobulin and calcitonin due to rheumatoid factor in non-relapsing thyroid carcinoma: A case report 195
Repositioning of Cefuroxime as novel selective inhibitor of the thyroid hormone activating enzyme type 2 deiodinase 188
The ocrelizumab wearing-off phenomenon is associated with reduced immunomodulatory response and increased neuroaxonal damage in multiple sclerosis 186
HNP-1 and HBD-1 as biomarkers for the immune systems of elite basketball athletes 181
New approaches in the diagnostic procedure of malignant pleural effusions 174
Incidence of fatigue and low-dose corticosteroid use in prostate cancer patients receiving systemic treatment: a meta-analysis of randomized controlled trials 173
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette–Guérin after transurethral resection of the bladder tumor 173
Sistema per la sanificazione automatizzata di contenitori per campioni biologici e suo procedimento di utilizzo 171
Vandetanib downregulates type 2 deiodinase in fibro/adipogenic progenitors 171
Analysis of glycoproteins in human colon cancers, normal tissues and in human colon carcinoma cells reactive with monoclonal antibody NCL-19-9 171
Oleic acid promotes prostate cancer malignant phenotype via the G protein-coupled receptor FFA1/GPR40 170
Urotensin II receptor on preoperative biopsy is associated with upstaging and upgrading in prostate cancer 169
Serum (-2)proPSA/freePSAratio, (-2)proPSA/freePSA density, prostate health index, and prostate health index density as clues to reveal postoperative clinically significant prostate cancer in men with prostate-specific antigen 2-10 ng/mL 167
Laboratory medicine: health evaluation in elite athletes 167
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer 164
How Does Physical Activity Modulate Hormone Responses? 163
A MOUSE MODEL DEMONSTRATES A MULTIGENIC ORIGIN OF CONGENITAL HYPOTHYROIDISM 162
A New Horizon of Liquid Biopsy in Thymic Epithelial Tumors: The Potential Utility of Circulating Cell-Free DNA 162
Athlete's Passport: Prevention of Infections, Inflammations, Injuries and Cardiovascular Diseases 161
Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis 161
Seroprevalence of SARS-CoV-2 Assessed by Four Chemiluminescence Immunoassays and One Immunocromatography Test for SARS-Cov-2 159
Impact of Age on Outcomes of Patients With Pure Carcinoma In Situ of the Bladder: Multi-Institutional Cohort Analysis 158
Cyclic AMP-dependent secretion of Ca 19-9 by LS 174T human colon carcinoma cells 157
Comparison between a new thyroglobulin assay with the well-established Beckman Access immunoassay: A preliminary report 157
alpha1(I) collagen gene expression in quail epiphyseal chondrocytes. 156
Quercetin and its derivative Q2 modulate chromatin dynamics in adipogenesis and Q2 prevents obesity and metabolic disorders in rats 156
Thyroid Hormone Regulates the Lipid Content of Muscle Fibers, Thus Affecting Physical Exercise Performance 155
Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance 155
Metabolomic profiling for the identification of novel diagnostic markers and therapeutic targets in prostate cancer: an update 155
Colorimetric Test for Fast Detection of SARS-CoV-2 in Nasal and Throat Swabs 155
Thyroid targeting of the N-ras(Gln61Lys) oncogene in transgenic mice results in follicular tumors that progress to poorly differentiated carcinomas. 153
Iodine status assessment in Campania (Italy) as determined by urinary iodine excretion. 151
Long non-coding RNA containing ultraconserved genomic region 8 promotes bladder cancer tumorigenesis 151
Identification of serum biomarkers for the prevention of inflammation, infection, muscle injuries and cardiovascular disease in competitive athletes 150
Leptin enhances the intracellular thyroid hormone activation in skeletal muscle to boost energy balance 150
Matrix metalloproteinase-2 and -9 in the urine of prostate cancer patients. 150
Diagnostic and Therapeutic Potential for HNP-1, HBD-1 and HBD-4 in Pregnant Women with COVID-19 149
The Impact of Meat Intake on Bladder Cancer Incidence: Is It Really a Relevant Risk? 149
Preoperative insulin-like growth factor-binding protein-3 (IGFBP-3) blood level predicts gleason sum upgrading 149
Effects of the ErbB1/ErbB2 kinase inhibitor GW2974 on androgen-independent prostate cancer PC-3 cell line growth and NSE, chromogranin A and osteopontin content. 148
Prostate health index (phi) and prostate cancer antigen 3 (PCA3) significantly improve diagnostic accuracy in patients undergoing prostate biopsy 148
Improving the prediction of pathologic outcomes in patients undergoing radical prostatectomy: the value of prostate cancer antigen 3 (PCA3), prostate health index (phi) and sarcosine 148
Urinary gelatinase activities (matrix metalloproteinases 2 and 9) in human bladder tumors 147
Gelatinolytic activities (matrix metalloproteinase-2 and -9) and soluble extracellular domain of Her-2/neu in pleural effusions. 146
Prostate health index vs percent free prostate-specific antigen for prostate cancer detection in men with "gray" prostate-specific antigen levels at first biopsy: Systematic review and meta-analysis 146
Biomarkers in localized prostate cancer 146
Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis 146
Artificial Intelligence and Machine Learning in Prostate Cancer Patient Management-Current Trends and Future Perspectives 146
Modified glasgow prognostic score is associated with risk of recurrence in bladder cancer patients after radical Cystectomy: A multicenter experience 145
Role of cytokeratins, nuclear matrix proteins, Lewis antigen and epidermal growth factor receptor in human bladder tumors. 144
Urinary long noncoding RNAs in nonmuscle-invasive bladder cancer: new architects in cancer prognostic biomarkers 144
Epigenetic signature: A new player as predictor of clinically significant prostate cancer (PCa) in patients on active surveillance (AS) 144
Predictors of residual T1 high grade on re-transurethral resection in a large multi-institutional cohort of patients with primary T1 high-grade/grade 3 bladder cancer 144
Systemic combining inflammatory score (SCIS): a new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancer 144
Liquid biopsy in bladder cancer: State of the art and future perspectives 144
Prostate health index and multiparametric mri: Partners in crime fighting overdiagnosis and overtreatment in prostate cancer 144
Expression of Lewis carbohydrate antigen in human tumors. 143
Beyond PSA: The Role of Prostate Health Index (phi) 143
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy 143
Adenoviral gene transfer of PLD1-D4 enhances insulin sensitivity in mice by disrupting phospholipase D1 interaction with PED/PEA-15. 142
Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicentre study 142
Neurofilament light chain and Alzheimer pathology biomarkers in elderly people with multiple sclerosis 141
BNT162b2 Elicited an Efficient Cell-Mediated Response against SARS-CoV-2 in Kidney Transplant Recipients and Common Variable Immunodeficiency Patients 141
New strategy for the identification of prostate cancer: The combination of Proclarix and the prostate health index 140
Clinical application of age-derived cut-offs for plasma neurofilament light chain in multiple sclerosis 139
First-line systemic therapy for metastatic castration-sensitive prostate cancer: An updated systematic review with novel findings 139
Diagnostic value of carbohydrate antigens in supernatantsand sediments of pleural effusions 138
Subcellular Localization of uc.8+ as a Prognostic Biomarker in Bladder Cancer Tissue 138
Neutrophil, platelets, and eosinophil to lymphocyte ratios predict gleason score upgrading in low-risk prostate cancer patients 137
Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non–muscle-invasive Bladder Cancer 136
Peri-Prostatic Adipocyte-Released TGFβ Enhances Prostate Cancer Cell Motility by Upregulation of Connective Tissue Growth Factor 135
Enhanced liver fibrosis score as a noninvasive biomarker in hepatitis C virus patients after direct-acting antiviral agents 133
Human defensins: Potential role in the Immune System of Professional Basketball Athletes 133
The contribution of omental adipose tissue to adipokine concentrations in patients with the metabolic syndrome. 133
Integration of lipidomics and transcriptomics reveals reprogramming of the lipid metabolism and composition in clear cell renal cell carcinoma 133
Prostate cancer radiogenomics—from imaging to molecular characterization 133
Impact of smoking exposure on disease progression in high risk and very high-risk nonmuscle invasive bladder cancer patients undergoing BCG therapy 132
Soluble interleukin-6 receptor to interleukin-6 (sIL-6R/IL-6) ratio in serum as a predictor of high Gleason sum at radical prostatectomy 131
Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) Significantly Improve Prostate Cancer Detection at Initial Biopsy in a Total PSA Range of 2-10 ng/ml 131
Body mass index was associated with upstaging and upgrading in patients with low-risk prostate cancer who met the inclusion criteria for active surveillance 131
Optimized Identification of High-Grade Prostate Cancer by Combining Different PSA Molecular Forms and PSA Density in a Deep Learning Model 130
Circulating tissue inhibitor of metalloproteinases 1 (TIMP-1) at COVID-19 onset predicts severity status 129
Rhes is involved in strial function 129
Thyrotropin (tsh) directly and acutely affects vascular reactivity in humans 129
Childhood obesity: an overview of laboratory medicine, exercise and microbiome 129
Liquid biopsy biomarkers in urine: A route towards molecular diagnosis and personalized medicine of bladder cancer 129
Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette–Guerin Immunotherapy 129
The evolving role of monoclonal antibodies in the treatment of patients with advanced renal cell carcinoma: a systematic review 128
Evaluation of a fully closed real time PCR platform for the detection of SARS-CoV-2 in nasopharyngeal swabs: a pilot study 128
Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG 127
Liquid Biopsy in Prostate Cancer Management{\textemdash}Current Challenges and Future Perspectives 127
Conditional inactivation of the E-cadherin gene in thyroid follicular cells affects gland development but does not impair junction formation. 127
Identification of genes controlled by the Foxe 1 transcription factor 127
Salvage radical prostatectomy after external beam radiation therapy: A systematic review of current approaches 127
Time to progression is the main predictor of survival in patients with high-risk nonmuscle invasive bladder cancer: Results from a machine learning-based analysis of a large multi-institutional database 126
Totale 15.142
Categoria #
all - tutte 72.234
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.234


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022856 18 12 11 3 21 12 24 31 86 83 262 293
2022/20231.267 140 102 48 59 148 138 16 126 183 197 83 27
2023/20241.081 38 134 206 112 69 95 18 132 27 23 148 79
2024/20255.601 206 220 12 67 214 290 539 336 395 601 2.249 472
2025/202613.131 1.242 1.014 1.361 1.376 2.099 554 1.486 716 1.580 854 387 462
2026/2027521 521 0 0 0 0 0 0 0 0 0 0 0
Totale 23.640